Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Post-transcriptional regulation by cytosine-5 methylation of RNA

  • García-Vílchez, Raquel
  • Sevilla Hernández, Ana
  • Blanco, Sandra
The recent advent of high-throughput sequencing technologies coupled with RNA modifications detection methods has allowed the detection of RNA modifications at single nucleotide resolution giving a more comprehensive landscape of post-transcriptional gene regulation pathways. In this review, we focus on the occurrence of 5-methylcytosine (m5C) in the transcriptome. We summarise the main findings of the molecular role in post-transcriptional regulation that governs m5C deposition in RNAs. Functionally, m5C deposition can regulate several cellular and physiological processes including development, differentiation and survival to stress stimuli. Despite many aspects concerning m5C deposition in RNA, such as position or sequence context and the fact that many readers and erasers still remain elusive, the overall recent findings indicate that RNA cytosine methylation is a powerful mechanism to post-transcriptionally regulate physiological processes. In addition, mutations in RNA cytosine-5 methyltransferases are associated to pathological processes ranging from neurological syndromes to cancer., R.G-V is a PhD student supported by the Spanish Ministry of Economy and Innovation (MINECO) PhD fellowship (BES-2017-080530). A. S. is a recipient of a Ramón y Cajal contract (RYC-2016-19962). S.B. is a Research Scientist (Científico Titular) of the Spanish Research Council (CSIC) and has been supported by a Ramón y Cajal fellowship for junior investigators (RYC-2014-16550). We acknowledge funding from the Spanish Ministry of Economy and Innovation (MINECO) and Agencia Estatal de Investigación (AEI) and co-financed by the European Development Regional Fund (FEDER) under grant no. SAF2016-78667-R. We thank the Spanish Ministry if Economy and Innovation for the Ochoa Excellence Accreditation of CIC bioGUNE (SEV-2016-0644). We gratefully thank Peter Humphreys for his editorial contribution. S.B.'s institution is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia cofunded by the Castilla–León autonomous government and the European Regional Development Fund (CLC–2017–01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Emerging roles of novel small non-coding regulatory RNAs in immunity and cancer

  • Rosace, Domenico
  • López, Judith
  • Blanco, Sandra
The term small non-coding RNAs (ncRNAs) refers to all those RNAs that even without encoding for a protein, can play important functional roles. Transfer RNA and ribosomal RNA derived fragments (tRFs and rRFs, respectively) are an emerging class of ncRNAs originally considered as simple degradation products, which though play important roles in stress responses, signalling or gene expression. They control all levels of gene expression regulating transcription and translation and affecting RNA processing and maturation. They have been linked to pivotal cellular processes such as self-renewal, differentiation and proliferation. For this reason, mis-regulation of this novel class of ncRNAs can lead to various pathological processes such as neurodegenerative and development diseases, metabolism and immune system disorders and cancer. In this review we summarize the classification, biogenesis and functions of tRFs and rRFs with a special focus on their role in immunity and cancer., D.R. is supported by Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia co-funded by the Castilla–León autonomous government and the European Regional Development Fund (CLC–2017–01). J.L. is a PhD student supported by a The Scientific Foundation AECC (Spanish Association Against Cancer) PhD fellowship (PRDSA19002LÓPE). S.B. is a Research Scientist of the Spanish Research Council. We acknowledge funding from the Spanish Ministry of Economy and Innovation (MINECO) and Agencia Estatal de Investigación (AEI) and co-financed by the European Development Regional Fund (FEDER) under grant no. SAF2016-78667-R (AEI/FEDER, UE). In addition we acknowledge funding from The Scientific Foundation AECC under grant no. LABAE19040BLAN, and the University of Salamanca and Fundación Memoria de Samuel Solorzano Barruso under grant no. FS/21-2018. AUTHOR’s institution is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia cofunded by the Castilla–León autonomous government and the European Regional Development Fund (CLC–2017–01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Glia crosstalk in neuroinflammatory diseases

  • Bernaus, Ada
  • Blanco, Sandra
  • Sevilla Hernández, Ana
Neuroinflammation constitutes a fundamental cellular process to signal the loss of brain homeostasis. Glial cells play a central role in orchestrating these neuroinflammation processes in both deleterious and beneficial ways. These cellular responses depend on their intercellular interactions with neurons, astrocytes, the blood–brain barrier (BBB), and infiltrated T cells in the central nervous system (CNS). However, this intercellular crosstalk seems to be activated by specific stimuli for each different neurological scenario. This review summarizes key studies linking neuroinflammation with certain neurodegenerative diseases such as Alzheimer disease (AD), Parkinson disease (PD), and amyotrophic lateral sclerosis (ALS) and for the development of better therapeutic strategies based on immunomodulation., AS is supported by the Spanish Ministry of Economy and Innovation (MINECO) and Agencia Estatal de Investigación (AEI), and the European Development Regional Fund (FEDER; PGC2018-098626-B100). She is also supported by a grant from the Merck Foundation. AB is a recipient of a collaboration grant from the Spanish Ministry of Economy and Innovation (MINECO) and Agencia Estatal de Investigación (AEI). SB is supported by the Spanish Ministry of Economy and Innovation (MINECO), Agencia Estatal de Investigación (AEI), co-financed by the European Development Regional Fund (FEDER) under (SAF2016-78667-R), The Scientific Foundation AECC (LABAE19040BLAN), the University of Salamanca and Fundación Memoria de Samuel Solorzano Barruso (FS/21-2018), the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia cofunded by the Castilla–León autonomous government and the European Regional Development Fund (CLC-2017-01). AS is a recipient of a Ramón y Cajal contract (RYC-2016-19962)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities

  • Nombela, Paz
  • Miguel-López, Borja
  • Blanco, Sandra
© The Author(s)., RNA modifications have recently emerged as critical posttranscriptional regulators of gene expression programmes. Significant advances have been made in understanding the functional role of RNA modifications in regulating coding and non-coding RNA processing and function, which in turn thoroughly shape distinct gene expression programmes. They affect diverse biological processes, and the correct deposition of many of these modifications is required for normal development. Alterations of their deposition are implicated in several diseases, including cancer. In this Review, we focus on the occurrence of N6-methyladenosine (m6A), 5-methylcytosine (m5C) and pseudouridine (Ψ) in coding and non-coding RNAs and describe their physiopathological role in cancer. We will highlight the latest insights into the mechanisms of how these posttranscriptional modifications influence tumour development, maintenance, and progression. Finally, we will summarize the latest advances on the development of small molecule inhibitors that target specific writers or erasers to rewind the epitranscriptome of a cancer cell and their therapeutic potential., This work was supported by Spanish Ministry of Economy and Innovation (MINECO), Ministry of Science and Innovation and Agencia Estatal de Investigación (AEI) and co-financed by the European Development Regional Fund (FEDER) under grant no. SAF2016–78667-R (AEI/FEDER, UE) and PID2019-111692RB-I00. In addition we acknowledge funding from The Scientific Foundation AECC under grant no. LABAE19040BLAN. BML was supported by Junta de Castilla y León-Fondo Social Europeo (ESF) predoctoral fellowship. AUTHOR’s institution is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia co-financed by the Castilla–León autonomous government and the European Regional Development Fund (CLC–2017–01), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer

  • García-Vílchez, Raquel
  • Añazco-Guenkova, Ana M.
  • López, Judith
  • Dietmann, Sabine
  • Tomé, Mercedes
  • Jimeno, Sonia
  • Azkargorta, Mikel
  • Elortza, Félix
  • Bárcena, Laura
  • Gonzalez-Lopez, Monika
  • Aransay, Ana M.
  • Sánchez-Martín, Manuel A.
  • Huertas Sánchez, Pablo
  • Durán, Raúl V.
  • Blanco, Sandra
Tumour progression and therapy tolerance are highly regulated and complex processes largely dependent on the plasticity of cancer cells and their capacity to respond to stress. The higher plasticity of cancer cells highlights the need for identifying targetable molecular pathways that challenge cancer cell survival. Here, we show that N7-guanosine methylation (m7G) of tRNAs, mediated by METTL1, regulates survival to stress conditions in cancer cells. Mechanistically, we find that m7G in tRNAs protects them from stress-induced cleavage and processing into 5' tRNA fragments. Our analyses reveal that the loss of tRNA m7G methylation activates stress response pathways, sensitising cancer cells to stress. Furthermore, we find that the loss of METTL1 reduces tumour growth and increases cytotoxic stress in vivo. Our study uncovers the role of m7G methylation of tRNAs in stress responses and highlights the potential of targeting METTL1 to sensitise cancer cells to chemotherapy., This work was funded by the Spanish Ministry of Science and Innovation MICINN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe”, by the “European Union” (SAF2016-78667-R and PID2019-111692RB-I00), MINECO (RYC-2014-16550), AECC (LABAE19040BLAN), and Consejería de Educación de la Junta de Castilla y León (CSI264P20) to S.B. R.G-V. was supported by MICINN/AEI /10.13039/501100011033 and by “ESF Investing in your future” (BES-2017-080530). A.M.A-G. was supported by USAL-Santander PhD fellowship. J.L. was supported by AECC (PRDSA19002LÓPE) and MIU (FPU19/01190). The Instituto de Biología Molecular y Celular del Cancer is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia co-financed by the Castilla–León autonomous government and the European Regional Development Fund (CLC–2017–01). R.V.D. work was supported by Agencia Estatal de Investigación/European Regional Development Fund, European Union (PGC2018-096244-B-I00, Ministry of Science and Innovation of Spain, Spanish National Research Council-CSIC (2021AEP005). The authors wish to thank the donors, and the Biobank Hospital Universitario Puerta de Hierro Majadahonda (HUPHM)/Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA) (PT17/0015/0020 in the Spanish National Biobanks Network) for the human specimens used in this study. The authors wish to thank all the core facilities that support the work., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

  • García-Vílchez, Raquel
  • Añazco-Guenkova, Ana M.
  • Dietmann, Sabine
  • López, Judith
  • Morón-Calvente, Virginia
  • D'Ambrosi, Silvia
  • Nombela, Paz
  • Zamacola, Kepa
  • Mendizábal, Isabel
  • García-Longarte, Saioa
  • Zabala-Letona, Amaia
  • Astobiza, Ianire
  • Fernández, Sonia
  • Paniagua, Alejandro
  • Miguel-López, Borja
  • Marchand, Virginie
  • Alonso-López, Diego
  • Merkel, Angelika
  • García-Tuñón, Ignacio
  • Ugalde-Olano, Aitziber
  • Loizaga-Iriarte, Ana
  • Lacasa-Viscasillas, Isabel
  • Unda, Miguel
  • Azkargorta, Mikel
  • Elortza, Félix
  • Bárcena, Laura
  • Gonzalez-Lopez, Monika
  • Aransay, Ana M.
  • Di Domenico, Tomás
  • Sánchez-Martín, Manuel A.
  • De Las Rivas, Javier
  • Guil, Sònia
  • Motorin, Yuri
  • Helm, Mark
  • Pandolfi, Pier Paolo
  • Carracedo, Arkaitz
  • Blanco, Sandra
Newly growing evidence highlights the essential role that epitranscriptomic marks play in the development of many cancers; however, little is known about the role and implications of altered epitranscriptome deposition in prostate cancer. Here, we show that the transfer RNA N7-methylguanosine (m7G) transferase METTL1 is highly expressed in primary and advanced prostate tumours. Mechanistically, we find that METTL1 depletion causes the loss of m7G tRNA methylation and promotes the biogenesis of a novel class of small non-coding RNAs derived from 5'tRNA fragments. 5'tRNA-derived small RNAs steer translation control to favour the synthesis of key regulators of tumour growth suppression, interferon pathway, and immune effectors. Knockdown of Mettl1 in prostate cancer preclinical models increases intratumoural infiltration of pro-inflammatory immune cells and enhances responses to immunotherapy. Collectively, our findings reveal a therapeutically actionable role of METTL1-directed m7G tRNA methylation in cancer cell translation control and tumour biology., This work was funded by the Spanish Ministry of Science and Innovation MICINN/AEI/1013039/501100011033 and by “ERDF A way of making Europe”, by the “European Union” (SAF2016-78667-R and PID2019-111692RB-I00), MINECO (RYC-2014-16550), AECC (LABAE19040BLAN), Proteored-ISCIII, and Consejería de Educación de la Junta de Castilla y León (CSI264P20). R.G-V. was supported by MICINN/AEI/1013039/501100011033 and by “ESF Investing in your future” (BES-2017-080530). A.M.A-G. was supported by the USAL-Santander PhD fellowship. J.L-L. was supported by the AECC (PRDSA19002LÓPE) and MIU(FPU19/01190). B.M.L. was supported by Junta de Castilla y León ‐ Fondo Social Europeo (ESF). I.M. was supported by the Cris contra el cáncer grant PR_TPD_2020-19. The work of A. Carracedo is supported by the MICINN (PID2019-108787RB-I00 (FEDER/EU); Excellence Networks RED2018-102769-T), the AECC (GCTRA18006CARR), La Caixa Foundation (ID 100010434), under the agreement LCF/PR/HR17/ and the European Research Council (Consolidator Grant 819242). CIBERONC was co-funded by FEDER funds and ISCIII. The Instituto de Biología Molecular y Celular del Cancer is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia co-financed by the Castilla–León autonomous government and the European Regional Development Fund (CLC–2017–01)., Peer reviewed